How Research Funding Drives the Development of Life-Changing Medicines
Since its approval in 2001, Gleevec has represented a pivotal advancement in the treatment of chronic myeloid leukemia (CML), revolutionizing...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Since its approval in 2001, Gleevec has represented a pivotal advancement in the treatment of chronic myeloid leukemia (CML), revolutionizing...
In a recent meta-analysis published in Advances in Therapy, researchers Zheng, Mojebi, and Tang, alongside their colleagues, have unveiled significant...
Recent research highlights the potential of targeting PinX1 in the treatment of non-small cell lung cancer (NSCLC), particularly in enhancing...
image: An MSK reseacher works in the lab. view more Credit: Memorial Sloan Kettering Cancer Center New research from Memorial Sloan...
In a bold and unified stance that underscores the pivotal role of preventive medicine, the VCU Massey Comprehensive Cancer Center...
In a groundbreaking study published in BMC Cancer, researchers have unveiled intricate links between systemic inflammation, gut microbiota alterations, and...
A groundbreaking new analysis published in JAMA Oncology reveals that the effect of low-dose aspirin on cancer prevention among the...
Researchers unveil a groundbreaking immune-based genomic signature that promises to revolutionize treatment strategies for hormone receptor-positive, HER2-negative breast cancer by...
In a groundbreaking multi-center, real-world study recently published in BMC Cancer, researchers unveil critical insights into the clinical efficacy of...
A groundbreaking study by researchers at the Anhui Institute of Optics and Fine Mechanics (AIOFM), part of the Hefei Institutes...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine